-
CanSino gets COVID-19 vaccine patent from China’s IP regulator
expresspharma
August 18, 2020
CanSino Biologics has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, reported state media, citing documents from the country’s intellectual property regulator.
-
India in talks with developer of Russian COVID-19 vaccine: The Indian Express
expresspharma
August 18, 2020
Russian regulators recently approved the Sputnik V vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology, Moscow.
-
AstraZeneca concludes agreement with the European Commission for the supply of up to 400 million doses of AZD1222 COVID-19 vaccine
worldpharmanews
August 17, 2020
AstraZeneca has concluded an agreement with the European Commission (EC) to supply up to 400 million doses of the AZD1222 COVID-19 vaccine.
-
Aurobindo Pharma expects Phase I and II trials of COVID-19 vaccine by end of 2020
expresspharma
August 17, 2020
The company's viral vaccine manufacturing capacity in India would be undertaken in two phases, the first phase would be ready by October and the commercial facility by March, next year.
-
UK signs deals with J&J, Novavax for COVID-19 vaccine supplies
expresspharma
August 17, 2020
The latest agreements bring Britain’s total number of doses secured to 362 million for a population of 66 million.
-
Russia begins production of COVID-19 vaccine
expresspharma
August 17, 2020
It would be producing about five million doses a month by December-January, Interfax said.
-
COVID-19 vaccines to be monitored post-marketing by consortium in UK
europeanpharmaceuticalreview
August 14, 2020
The ‘One Million Post-Authorisation Study’ has been established to monitor the safety and effectiveness of COVID-19 vaccines in real-life conditions.
-
Brazil’s Parana state to produce Russia’s Covid-19 vaccine
pharmaceutical-technology
August 14, 2020
The Russian Direct Investment Fund (RDIF) and the Brazilian state of Parana are set to collaborate to produce and distribute Russia’s registered Covid-19 vaccine, Sputnik V.
-
Argentina and Mexico to make AstraZeneca COVID-19 vaccine for Latin America
expresspharma
August 14, 2020
The deal between AstraZeneca and mAbxience of the INSUD Group includes technology to initially produce 150 million doses of the vaccine for all of Latin America except Brazil.
-
Novavax announces collaboration with SK bioscience for COVID-19 vaccine
expresspharma
August 14, 2020
SK bioscience will manufacture the vaccine antigen component for use in the final drug product globally during the pandemic period.